Patient follow up after treatment for SGC

Share this article

Currently in the UK we do not have national guidance for the diagnosis and treatment of Salivary Gland Cancers.  SGC UK has provided funding to change and updates will follow in H2 of 2024.  In the meantime, we have put together some relevant international guidelines, papers and podcasts.  The two podcasts were created 2020/1 and since that time ESMO and ASCO have put out guidelines. 

Scans, follow-ups and nomograms (SGC UK podcast)

Medical oncologist Dr Robert Metcalf talks about scans, in particular MRI and CT scans, and their role in discovering and monitoring disease in ACC.

How often should you have scans? Does an MRI scan show ACC growing on your nerves? What is a nomogram and how can it help in discussions with your clinicians?

A podcast of this scan discussion can be found here and is now available to listen to and download.

  • Nomograms for predicting survival and recurrence in patients with Adenoid Cystic Carcinoma.  An international collaborative study (2015).  The paper can be accessed here.

Treatment options for metastatic disease (or 'mets') (SGC UK podcast)

Medical Oncologist Dr Robert Metcalf talks about treatment options for metastatic disease and when they might, or might not be used. 

The podcast of the discussion is here and available to listen to and download.

European Society of Medical Oncology (ESMO) 

European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guidelines for diagnosis, treatment and follow-up (2022)

The guidelines can be accessed here.  On page 12 you can see the long terms follow up recommendations.  SGC UK worked with Professor Carla van Herpen on these guidelines and she joined us from the Netherlands via zoom to talk about the process in Feb 2022.  You can see a recording of her talk here: 'The ESMO Guidelines on Salivary Gland Cancers - process and publication'

American Society of Clinical Oncology (ASCO) 

American Society of Clinical Oncology (ASCO) Management of Salivary Gland Malignancy: ASCO Guideline (2021)

The guidelines can be accessed here.